Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Recursion Pharmaceuticals, Inc.
  6. Consensus
    RXRX   US75629V1044

RECURSION PHARMACEUTICALS, INC.

(RXRX)
  Report
Delayed Nasdaq  -  04:00 2022-08-16 pm EDT
12.32 USD   -4.94%
08/11Goldman Sachs Adjusts Recursion Pharmaceuticals' Price Target to $8 From $7, Keeps Neutral Rating
MT
08/09RECURSION PHARMACEUTICALS : Q2 Earnings Snapshot
AQ
08/09RECURSION PHARMACEUTICALS : Provides Business Updates and Reports Second Quarter 2022 Financial Results - Form 8-K
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on RECURSION PHARMACEUTICALS, INC.
Target Price consensus revisions : last 18 months
Recommendations (Chart) RECURSION PHARMACEUTICALS, INC.
Analyst Recommendations on RECURSION PHARMACEUTICALS, INC.
08/11Goldman Sachs Adjusts Recursion Pharmaceuticals' Price Target to $8 From $7, Keeps Neutral..
MT
06/22Berenberg Bank Adjusts Recursion Pharmaceuticals' Price Target to $38 From $36, Maintains ..
MT
05/24Goldman Sachs Lowers Recursion Pharmaceuticals' Price Target to $7 From $9, Neutral Rating..
MT
04/18BofA Securities Downgrades Recursion Pharmaceuticals to Neutral from Buy
MT
03/24Goldman Sachs Adjusts Recursion Pharmaceuticals' Price Target to $10 from $32, Keeps Neutr..
MT
03/04SVB Leerink Downgrades Recursion Pharmaceuticals to Market Perform from Outperform, Adjust..
MT
03/04Berenberg Bank Trims Recursion Pharmaceuticals' Price Target to $36 From $37 on Delayed RE..
MT
More recommendations
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Last Close Price 12,32 $
Average target price 16,20 $
Spread / Average Target 31,5%
High Price Target 38,00 $
Spread / Highest target 208%
Low Price Target 8,00 $
Spread / Lowest Target -35,1%
Consensus detail
Consensus revision (last 18 months)